Partial reversal of heparin anticoagulation by intravenous protamine in abciximab-treated patients undergoing percutaneous intervention

American Journal of Cardiology

Volumn 80, Issue 5, 1997, Pages 633-634

  Kereiakes, Dean J ^a   Broderick, Thomas M ^b   Whang, David D ^b   Anderson, Linda ^b   Fye, David ^b  

^a Carl and Edyth Linder Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; HEPARIN; PROTAMINE;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PROTAMINES;

EID: 0030984048     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00437-2     Document Type: Article

References (5)

1. The EPIC investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961.
2. Lincoff AM, Tcheng JE, Califf RM, Bass T, Popma JJ, Tiersten PS, Kleiman NS, Hattal LJ, Anderson HB, Ferguson JJ, Cabbott CF, Anderson KM, Berdan LJ, Musco MH, Weissman HF, Topol EJ. Standard versus low-dose weight adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab during percutaneous coronary revascularization. Am J Cardiol 1997;79:286-291.
3. Moliterno DJ, Califf RM, Aguirre FE, Anderson K, Sigmond KN, Weissman HF, Topol EJ. Effects of glycoprotein IIb/IIIa endocrine blockade on activated clotting time during percutaenous transmittal coronary angioplasty or directional athrectomy. Am J Cardiol 1995;75:559-562.
4. Ammar T, Scudder LE, Coller BS. In vitro effects of the platelet glycoprotein receptor antagonist C7E3 Fab on the activated clotting time. Circulation 1997;95:614-617.
5. Stoelting RK. Allergic reactions during anesthesia [review article]. Anesth Analg 1983;62:341-356.